NCT04196075View on ClinicalTrials.gov

The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 28, 2021

Study Completion Date

June 30, 2021

Conditions
Squamous Cell Carcinoma of Esophagus
Interventions
DRUG

Andrographis Paniculata

AP as palliative treatment

Trial Locations (1)

00000

Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04196075 - The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer | Biotech Hunter | Biotech Hunter